Palumbo Piccionello et al.
JOCNote
CHART 2
with MgSO4 and filtered, and the solvent was evaporated under
reduced pressure. Chromatography of the residue allowed iso-
lation of the corresponding 3-chloro-1,2,4-oxadiazoles 4i-m in
good yields.
3-Chloro-5-(4-trifluoromethylphenyl)-1,2,4-oxadiazole, 4i: 1.93 g,
68%; mp 66-67 °C (petroleum ether); 1H NMR (300 MHz,
CDCl3) δ 7.81 (d, 2H, J = 11.4 Hz), 8.24 (d, 2H, J = 11.4 Hz);
13C NMR (62.5 MHz, CDCl3) δ123.2 (q, J= 271 Hz), 126.3, 128.1,
128.5, 135.0 (q, J = 32.8 Hz), 162.2, 175.8; IR (Nujol) 1616,
1592 cm-1; GC-MS (m/z) 250 [(M þ 2)þ, 34%], 248
(Mþ, 100%). Anal. Calcd for C9H4ClF3N2O: C, 43.48; H, 1.62;
N, 11.27. Found: C, 43.50; H, 1.60; N, 11.25.
conversion of starting oxadiazole, and lower yield of final
triazoles 8. Therefore, the observed reactivity 4a > 4b >
4c > 4d > 4e seems to be strongly dependent on the leaving
group ability of the C(3) substituent rather than on its electronic
effect. Indeed, neither 3,5-diphenyl-, bearing a conjugating
C(3) substituent, nor 3-trifluoromethyl-5-phenyl-1,2,4-oxa-
diazole, bearing an electron-withdrawing C(3) substituent,
reacted under similar conditions.9a
On the other hand, there appears to be no correlation
between isolated yields of triazoles 8a-i and the type of
substitution at the C(5) of the oxadiazole’s ring. In fact, all
3-chloro-derivatives 4a and 4f-m reacted quantitatively
within 2 h without any significant difference in the time
required to observe complete conversion of the substrate.
In conclusion, the hydrazinolysis of 1,2,4-oxadiazole de-
rivatives 4 containing a leaving group directly linked at the
C(3) of the ring was investigated and an easy rearrangement
into amino-triazoles 8 through a reductive ANRORC was
evidenced. While previous studies have limited the application
of ANRORC rearrangements of 1,2,4-oxadiazoles to fluo-
rinated substrates, the reported results introduce the first
ANRORC reaction of nonfluorinated 1,2,4-oxadiazoles.
Besides opening the way to further mechanistic studies, the
high yields obtained suggest considering this methodology as
a general approach for the designed synthesis of functiona-
lized aminotriazoles which are well-known for their biological
activity.17
1
3-Chloro-5-benzyl-1,2,4-oxadiazole, 4j: 1.14 g, 59%; oil; H
C
NMR (300 MHz, CDCl3) δ 4.21 (s, 2H), 7.30-7.35 (m, 5H); 13
NMR (62.5 MHz, CDCl3) δ 33.3, 128.0, 129.0, 129.1, 132.5,
161.4, 180.2; IR (Nujol) 1568 cm-1; GC-MS (m/z) 196
[(M þ 2)þ, 32%], 194 (Mþ, 100%). Anal. Calcd for C9H7ClN2O:
C, 55.54; H, 3.63; N, 14.39. Found: C, 55.50; H, 3.60; N, 14.40.
3-Chloro-5-(2-furanyl)-1,2,4-oxadiazole, 4k: 1.26 g, 74%; mp
83-84 °C (petroleum ether); 1H NMR (300 MHz, CDCl3) δ 6.63
(dd, 1H, J1 = 3.6 Hz, J2 = 1.5 Hz), 6.35 (d, 1H, J = 3.6 Hz), 7.69
(d, 1H, J = 1.5 Hz); 13C NMR (62.5 MHz, CDCl3) δ 112.8,
118.0, 139.1, 147.6, 161.7, 168.8; IR (Nujol) 3111, 1624,
1540 cm-1; GC-MS (m/z) 172 [(M þ 2)þ, 33%], 170
(Mþ, 100%). Anal. Calcd for C6H3ClN2O2: C, 42.25; H, 1.77;
N, 16.43. Found: C, 42.25; H, 1.80; N, 16.40.
3-Chloro-5-(2-thiophenyl)-1,2,4-oxadiazole, 4l: 1.60 g, 81%;
mp 37-39 °C (petroleum ether); 1H NMR (300 MHz, CDCl3) δ
7.21-7.24 (m, 1H), 7.71 (d, 1H, J = 5.1 Hz), 7.93 (d, 1H, J =
3.6 Hz); 13C NMR (62.5 MHz, CDCl3) δ 124.5, 128.8, 132.9,
133.4, 161.6, 172.8; IR (Nujol) 3080, 1684, 1647, 1593,
1578 cm-1; GC-MS (m/z) 188 [(M þ 2)þ, 33%], 186
(Mþ, 100%). Anal. Calcd for C6H3ClN2OS: C, 38.62; H, 1.62;
N, 15.01. Found: C, 38.65; H, 1.60; N, 15.00.
3-Chloro-5-(4-pyridyl)-1,2,4-oxadiazole, 4m: 1.05 g, 58%; mp
96-97 °C (petroleum ether); 1H NMR (300 MHz, CDCl3) δ 7.96
(d, 2H, J = 3.0 Hz), 8.90 (d, 1H, J = 3.0 Hz); 13C NMR
(62.5 MHz, CDCl3) δ 121.0, 130.0, 151.3, 162.4, 175.3; IR
(Nujol) 1610, 1578, 1543 cm-1; GC-MS (m/z) 183 [(M þ 2)þ,
34%], 181 (Mþ, 100%). Anal. Calcd for C7H4ClN3O: C, 46.30;
H, 2.22; N, 23.14. Found: C, 46.40; H, 2.20; N, 23.20.
Experimental Section
General Procedure for the Reaction of 1,2,4-Oxadiazoles
4a-m with Hydrazine. A 2 mL sample of hydrazine hydrate
(41 mmol) was added to a stirred solution of oxadiazole 4
(1 mmol) in dry DMF (2 mL) and the mixture was kept at rt for
the time reported in Table 1. The solvent was then evaporated
under reduced pressure and the residue treated with water,
neutralized with 1 M aqueous HCl, and extracted with EtOAc.The
organic layer was dried over MgSO4 then filtered, and the solvent
was removed under reduced pressure. Chromatography of the
residue allowed isolation of the corresponding 3(5)-amino-5(3)-
aryl-1,2,4-triazoles 8 (Table 1). For compounds 8a-d,18 8f,19
and 8g-i18 spectroscopic data matched those reported in the
cited literature.
Materials and Methods. Melting points were determined on a
hot-stage apparatus and are uncorrected. FT-IR spectra were
registered in Nujol mull. 1H NMR and 13C NMR spectra were
recorded at 300 and 62.5 MHz, respectively, using TMS as an
internal standard. Flash chromatography was performed by
using silica gel (0.040-0.063 mm) and mixtures of ethyl acetate
and petroleum ether (fraction boiling in the range of 40-60 °C)
in various ratios. Compounds 4a,b,15a 4c,15f 4d,15b 4e,15e and
4f-h15a were obtained as previously reported.
General Procedure for the Synthesis of 3-Chloro-1,2,4-oxadia-
zoles 4i-m. Compounds 4i-m were obtained adapting a pre-
viously reported method.15a
To a stirred solution of the appropriate amine 9a-e15b-d
(Chart 2) (10 mmol) in concentrated HCl (50 mL) at 0 °C was
added NaNO2 (11 mmol, 0.759 g) portion wise during 1 h. The
mixture was kept at rt until gas evolution ceased. Reaction
mixture was extracted with CHCl3, the organic phase was dried
3(5)-Amino-5(3)-(4-trifluoromethylphenyl)-1,2,4-triazole, 8e:
1
162 mg, 71%; mp 222-223 °C (EtOH); H NMR (300 MHz,
DMSO-d6) δ 6.26 (s, 2H, exch. with D2O), 7.81 (d, 2H, J =
8.4 Hz), 8.14 (d, 2H J = 8.4 Hz), 12.34 (s, 1H, exch. with D2O);
13C NMR (62.5 MHz, DMSO-d6) δ 129.5 (q, J = 270 Hz), 130.5,
131.0, 133.6 (q, J = 32 Hz), 141.2, 162.4, 162.9; IR (Nujol) 3420,
3291, 3188, 1679, 1640 cm-1; GC-MS (m/z) 228 (Mþ, 100%).
Anal. Calcd for C9H7F3N4: C, 47.37; H, 3.09; N, 24.55. Found:
C, 47.40; H, 3.10; N, 24.50.
(17) See among others: (a) Chen, C.; Dagnino, R., Jr.; Huang, C. Q.;
McCarthy, J. R.; Grigoriadis, D. E. Bioorg. Med. Chem. Lett. 2001, 11, 3165–
3168. (b) Lowe, R. F.; Nelson, J.; Dang, T. N.; Crowe, P. D.; Pahuja, A.;
McCarthy, J. R.; Grigoriadis, D. E.; Conlon, P.; Saunders, J.; Chen, C.;
Szabo, T.; Kung Chen, T.; Bozigian, H. J. Med. Chem. 2005, 48, 1540–1549.
(c) Akbarzadeh, T.; Tabatabai, S. A.; Khoshnoud, M. J.; Shafaghic, B.;
Shafieea, A. Bioorg. Med. Chem. 2003, 11, 769–773. (d) Naito, Y.; Akahoshi,
F.; Takeda, S.; Okada, T.; Kajii, M.; Nishimura, H.; Sigiura, M.; Fukaya, C.;
Kagitani, Y. J. Med. Chem. 1996, 39, 3019–3029.
(18) Dolzhenko, A. V.; Pastorin, G.; Dolzhenko, A. V.; Chui, W. K.
Tetrahedron Lett. 2009, 50, 2124–2128.
(19) Dolzhenko, A. V.; Dolzhenko, A. V.; Chui, W. K. Heterocycles 2007,
71, 429–436.
8726 J. Org. Chem. Vol. 75, No. 24, 2010